Product Information
FOSFOMYCIN 3 GM SACHET is a generic product labeled by Xiromed LLC, priced at $26.2204 per EA under NDC 70700026894. Its NADAC has been published 298 times since Jan 20, 2021.
FDA first approved this application on Oct 6, 2020. Its Orange Book therapeutic-equivalence code is AA.
Strength
3 g/1
Manufacturer
Xiromed LLCNDC
70700026894
Classification
Generic
Dosage Form
POWDER
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FOSFOMYCIN TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA212548FDA Approved
10/6/2020
TE Code
AA
On Market Since
10/6/2020
Price Statistics
The NADAC for FOSFOMYCIN 3 GM SACHET has been published 298 times since Jan 20, 2021, and over the history we have for it it has declined 63.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.2204 per EA |
|---|---|
| All-time high | $71.3767 (Feb 10, 2021) |
| All-time low | $26.2204 (Sep 23, 2026) |
| 52-week high | $37.0316 |
| 52-week low | $26.2204 |
| Median price | $48.7116 |
| Average price | $50.1277 |
| Largest weekly change | -35.0% (Apr 17, 2024) |
| Weeks tracked | 298 |
| Tracking since | Jan 20, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Granules for Oral Solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FOSFOMYCIN 3 GM SACHET?
The current National Average Drug Acquisition Cost (NADAC) for FOSFOMYCIN 3 GM SACHET, manufactured by Xiromed LLC, is $26.2204 per EA (NDC 70700026894), effective Sep 30, 2026.
How has the price of FOSFOMYCIN 3 GM SACHET changed over time?
Over the history we have for it, the NADAC for FOSFOMYCIN 3 GM SACHET has declined 63.3%. It has been tracked across 298 weekly CMS publications since Jan 20, 2021.
What are the highest and lowest recorded NADAC prices for FOSFOMYCIN 3 GM SACHET?
Since Jan 20, 2021, the NADAC for FOSFOMYCIN 3 GM SACHET has ranged from a low of $26.2204 (Sep 23, 2026) to a high of $71.3767 (Feb 10, 2021), with a median of $48.7116 per EA.
Are there cheaper alternatives to FOSFOMYCIN 3 GM SACHET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FOSFOMYCIN 3 GM SACHET in a comparable dosage form, but none are currently priced below it.
Who manufactures FOSFOMYCIN 3 GM SACHET?
FOSFOMYCIN 3 GM SACHET (NDC 70700026894) is labeled by Xiromed LLC, and CMS classifies it as a generic product.